A detailed history of Met Life Investment Management, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 130,152 shares of ADMA stock, worth $2.27 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
130,152
Previous 130,152 -0.0%
Holding current value
$2.27 Million
Previous $1.46 Million 78.76%
% of portfolio
0.02%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.98 - $11.18 $129,724 - $242,527
21,693 Added 20.0%
130,152 $1.46 Million
Q1 2024

May 14, 2024

BUY
$4.4 - $6.74 $477,219 - $731,013
108,459 New
108,459 $715,000
Q2 2023

Apr 29, 2024

BUY
$3.12 - $4.22 $344,653 - $466,166
110,466 New
110,466 $407,000
Q1 2023

May 09, 2024

BUY
$3.01 - $3.87 $332,502 - $427,503
110,466 New
110,466 $366 Million
Q1 2023

May 15, 2023

BUY
$3.01 - $3.87 $69,561 - $89,435
23,110 Added 26.45%
110,466 $365,000
Q4 2022

May 10, 2024

SELL
$2.47 - $3.88 $26,927 - $42,299
-10,902 Reduced 11.1%
87,356 $338,000
Q4 2022

Jun 14, 2023

SELL
$2.47 - $3.88 $57,081 - $89,666
-23,110 Reduced 20.92%
87,356 $338,000
Q4 2022

Mar 22, 2023

SELL
$2.47 - $3.88 $26,927 - $42,299
-10,902 Reduced 11.1%
87,356 $338,000
Q4 2022

Feb 15, 2023

SELL
$2.47 - $3.88 $26,927 - $42,299
-10,902 Reduced 11.1%
87,356 $338,000
Q3 2022

Jun 14, 2023

SELL
$2.03 - $2.86 $24,782 - $34,914
-12,208 Reduced 11.05%
98,258 $238,000
Q2 2022

May 10, 2024

BUY
$1.43 - $2.2 $140,508 - $216,167
98,258 New
98,258 $194,000
Q2 2022

Jun 20, 2023

SELL
$1.43 - $2.2 $17,457 - $26,857
-12,208 Reduced 11.05%
98,258 $194,000
Q2 2022

Mar 22, 2023

BUY
$1.43 - $2.2 $87,777 - $135,042
61,383 Added 166.46%
98,258 $194,000
Q2 2022

Aug 11, 2022

BUY
$1.43 - $2.2 $140,508 - $216,167
98,258 New
98,258 $195,000
Q2 2020

Aug 14, 2020

SELL
$2.42 - $3.29 $89,237 - $121,318
-36,875 Closed
0 $0
Q1 2020

Jul 12, 2023

SELL
$1.5 - $4.59 $110,386 - $337,782
-73,591 Reduced 66.62%
36,875 $106,000
Q1 2020

Mar 22, 2023

BUY
$1.5 - $4.59 $15,801 - $48,351
10,534 Added 39.99%
36,875 $106,000
Q1 2020

May 15, 2020

BUY
$1.5 - $4.59 $55,312 - $169,256
36,875 New
36,875 $106,000
Q4 2019

Feb 14, 2020

SELL
$3.89 - $5.15 $102,466 - $135,656
-26,341 Closed
0 $0
Q3 2019

Jul 12, 2023

SELL
$3.19 - $5.39 $268,358 - $453,433
-84,125 Reduced 76.15%
26,341 $117,000
Q3 2019

Mar 22, 2023

SELL
$3.19 - $5.39 $194,637 - $328,870
-61,015 Reduced 69.85%
26,341 $117,000
Q3 2019

Nov 14, 2019

BUY
$3.19 - $5.39 $84,027 - $141,977
26,341 New
26,341 $117,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.42B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.